MIRM

Mirum Pharmaceuticals, Inc.

MIRM · CIK 1759425 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$521M
20192025
Net Income−$23M
20192025
Operating CF$56M
20192025
Free Cash Flow$55M
20192025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.5B$0.3B$0.2B$0.1B$0.0B——
Cost of Revenue———————
Gross Profit———————
R&D Expense———————
SG&A Expense$0.3B$0.2B$0.1B$0.1B———
Operating Income$-0.0B$-0.1B$-0.1B$-0.1B$-0.2B$-0.1B$-0.1B
Net Income$-0.0B$-0.1B$-0.2B$-0.1B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-0.47$-1.85$-4.00$-4.01———
EPS (Diluted)$-0.47$-1.85$-4.00$-4.02———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.8B$0.7B$0.6B$0.4B$0.3B$0.2B$0.1B
Current Assets$0.5B$0.4B$0.4B$0.2B$0.2B$0.2B$0.1B
Cash & Equivalents$0.3B$0.2B$0.3B$0.0B$0.0B$0.1B$0.0B
Total Liabilities$0.5B$0.4B$0.4B$0.2B$0.2B$0.1B$0.0B
Current Liabilities$0.2B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$0.3B$0.2B$0.2B$0.1B$0.1B$0.2B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$0.1B$0.0B$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B
Investing Cash Flow$-0.0B$-0.1B$-0.1B$0.0B$0.0B$0.0B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.3B$0.1B$0.1B$0.2B$0.1B
← Companies